Skip to main content
SpringerLink
Log in

Efficacy of live attenuated vaccines after two doses of intravenous immunoglobulin for Kawasaki disease

  • Research Letter
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American heart association. Circulation. 2017;135:e927–99.

    Article  Google Scholar 

  2. Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics. 1979;63:175–9.

    Article  CAS  Google Scholar 

  3. Research Committee of the Japanese Society of Pediatric Cardiology, Cardiac Surgery Committee for Development of Guidelines for Medical Treatment of Acute Kawasaki Disease. Guidelines for medical treatment of acute Kawasaki disease: report of the research committee of the Japanese society of pediatric cardiology and cardiac surgery (2012 revised version). Pediatr Int. 2014;56:135–58.

    Article  Google Scholar 

  4. de Graeff N, Groot N, Ozen S, Eleftheriou D, Avcin T, Bader-Meunier B, et al. European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease-the SHARE initiative. Rheumatology (Oxford). 2019;58:672–82.

    Article  Google Scholar 

  5. Kobrynski L. Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases. Biologics. 2012;6:277–87.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Miura M, Katada Y, Ishihara J. Time interval of measles vaccination in patients with Kawasaki disease treated with additional intravenous immune globulin. Eur J Pediatr. 2004;163:25–9.

    Article  CAS  Google Scholar 

  7. Morikawa Y, Sakakibara H, Kimiya T, Obonai T, Miura M. Tokyo pediatric clinical research network. Live attenuated vaccine efficacy six months after intravenous immunoglobulin therapy for Kawasaki disease. Vaccine. 2021;39:5680–7.

    Article  CAS  Google Scholar 

  8. Tacke CE, Smits GP, van der Klis FR, Kuipers IM, Zaaijer HL, Kuijpers TW. Reduced serologic response to mumps, measles, and rubella vaccination in patients treated with intravenous immunoglobulin for Kawasaki disease. J Allergy Clin Immunol. 2013;131:1701–3.

    Article  CAS  Google Scholar 

  9. Timing and spacing of immunobiologics. 2022. https://www.cdc.gov//vaccines/hcp/acip-recs/general-recs/timing.html. Accessed 10 Apr 2022.

  10. Siber GR, Werner BG, Halsey NA, Reid R, Almeido-Hill J, Garrett SC, et al. Interference of immune globulin with measles and rubella immunization. J Pediatr. 1993;122:204–11.

    Article  CAS  Google Scholar 

  11. Kamei K, Miyairi I, Ishikura K, Ogura M, Shoji K, Funaki T, et al. Prospective study of live attenuated vaccines for patients with nephrotic syndrome receiving immunosuppressive agents. J Pediatr. 2018;196:217-22.e1.

    Article  CAS  Google Scholar 

  12. Kuijpers TW, Wiegman A, van Lier RA, Roos MT, Wertheim-van Dillen PM, Pinedo S, et al. Kawasaki disease: a maturational defect in immune responsiveness. J Infect Dis. 1999;180:1869–77.

    Article  CAS  Google Scholar 

  13. Chui LW, Marusyk RG, Pabst HF. Measles virus specific antibody in infants in a highly vaccinated society. J Med Virol. 1991;33:199–204.

    Article  CAS  Google Scholar 

  14. Yeager AS, Davis JH, Ross LA, Harvey B. Measles immunization. Successes and failures. JAMA. 1977;237:347–51.

    Article  CAS  Google Scholar 

  15. Saitoh A, Okabe N. Recent progress and concerns regarding the Japanese immunization program: addressing the “vaccine gap”. Vaccine. 2014;32:4253–8.

    Article  CAS  Google Scholar 

  16. Sonobe T. Intravenous gamma-globulin therapy and vaccination. Shoni-Naika. 1994;26:1929–33 (in Japanese).

    Google Scholar 

  17. Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y. Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation. 2003;108:325–30.

    Article  Google Scholar 

  18. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633–9.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dr. Yuho Horikoshi of the Division of Infectious Diseases, Department of Pediatrics at Tokyo Metropolitan Children's Medical Center for his support; Ms. Makiko Yoshida, Ms. Yuriko Ozaki, and the staff at the Clinical Research Support Center of Tokyo Metropolitan Children’s Medical Center for their help with data management; Mr. Takashi Nakamoto and Ms. Masako Tomotsune for their assistance with data collection; and Mr. James Robert Valera for his assistance in reviewing and editing this manuscript. The authors would like to express their deep appreciation to all the participants and their parents and all the staff at the participating institutions.

Funding

This work was supported by a grant from the Tokyo Metropolitan Government and the Japan Kawasaki Disease Research Center.

Author information

Authors and Affiliations

  1. Clinical Research Support Center, Tokyo Metropolitan Children’s Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo, 183-8561, Japan

    Yoshihiko Morikawa & Masaru Miura

  2. Department of General Pediatrics, Tokyo Metropolitan Children’s Medical Center, Tokyo, Japan

    Hiroshi Sakakibara

  3. Department of Cardiology, Tokyo Metropolitan Children’s Medical Center, Tokyo, Japan

    Masaru Miura

Authors
  1. Yoshihiko Morikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroshi Sakakibara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masaru Miura
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YM conceptualized and designed the study, performed the statistical analysis, and drafted and revised the manuscript. HS coordinated the study, supervised the data collection, and revised the manuscript. MM helped to conceptualize and design the study, interpret the data, and review and revise the manuscript. All the authors approved the final version of the manuscript as submitted and agree to be accountable for all aspects of the work.

Corresponding author

Correspondence to Yoshihiko Morikawa.

Ethics declarations

Ethical approval

The ethics committee at each institute approved this study. The study is registered in UMIN Clinical Trials Registry (No. UMIN000007174, registration date: January 31, 2012; https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000008452).

Conflict of interest

MM received honoraria from the Japan Blood Products Organization, Teijin Pharma Limited, Nihon Pharmaceutical, and Mitsubishi Tanabe Pharma Corporation which were unrelated to the submitted work. The other authors have no conflicts of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file 1 (PDF 189 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Morikawa, Y., Sakakibara, H. & Miura, M. Efficacy of live attenuated vaccines after two doses of intravenous immunoglobulin for Kawasaki disease. World J Pediatr 18, 706–709 (2022). https://doi.org/10.1007/s12519-022-00594-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-022-00594-6

Search

Navigation